VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 61,464
Sort by:

2019 Nephrotic Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nephrotic Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nephrotic Syndrome. It presents in-depth analysis of Nephrotic Syndrome clinical trials across markets and companies ...

April 2019 102 pages

2019 Neuroblastoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neuroblastoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroblastoma. It presents in-depth analysis of Neuroblastoma clinical trials across markets and companies ...

April 2019 238 pages

2019 Neuroendocrine Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neuroendocrine Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuroendocrine Carcinoma. It presents in-depth analysis of Neuroendocrine Carcinoma clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neurofibromatoses Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses. It presents in-depth analysis of Neurofibromatoses clinical trials across markets and companies ...

April 2019 159 pages

2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Neurofibromatoses Type I (Von Recklinghausen’s Disease) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurofibromatoses Type I (Von Recklinghausen’s Disease ...

April 2019 118 pages

2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuromyelitis Optica (Devic’s Syndrome). It presents in-depth analysis of Neuromyelitis Optica (Devic’s Syndrome) clinical trials ...

April 2019 60 pages

2019 Neurotoxicity Syndromes Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neurotoxicity Syndromes Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neurotoxicity Syndromes. It presents in-depth analysis of Neurotoxicity Syndromes clinical trials across markets and companies ...

April 2019 116 pages

2019 Neutropenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Neutropenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neutropenia. It presents in-depth analysis of Neutropenia clinical trials across markets and companies ...

April 2019 219 pages

2019 Nicotine Addiction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nicotine Addiction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nicotine Addiction. It presents in-depth analysis of Nicotine Addiction clinical trials across markets and companies ...

April 2019 243 pages

2019 Nocturia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nocturia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturia. It presents in-depth analysis of Nocturia clinical trials across markets and companies ...

April 2019 81 pages

2019 Nocturnal Enuresis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nocturnal Enuresis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nocturnal Enuresis. It presents in-depth analysis of Nocturnal Enuresis clinical trials across markets and companies ...

April 2019 72 pages

2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... trial report- “2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non Alcoholic Fatty Liver Disease (NAFLD ...

April 2019 344 pages

2019 Non Malignant pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Non Malignant pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non Malignant pain. It presents in-depth analysis of Non Malignant pain clinical trials ...

April 2019 58 pages

2019 Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Alcoholic Steatohepatitis (NASH). It presents in-depth analysis of Non-Alcoholic Steatohepatitis (NASH) clinical trials ...

April 2019 331 pages

2019 Nonerosive Reflux Disease (NERD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Nonerosive Reflux Disease (NERD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nonerosive Reflux Disease (NERD). It presents in-depth analysis of Nonerosive Reflux Disease (NERD) clinical trials ...

April 2019 64 pages

2019 Non-ischemic Cardiomyopathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Non-ischemic Cardiomyopathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-ischemic Cardiomyopathy. It presents in-depth analysis of Non-ischemic Cardiomyopathy clinical trials across markets and companies ...

April 2019 46 pages

2019 Non-Proliferative Diabetic Retinopathy (NPDR) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Non-Proliferative Diabetic Retinopathy (NPDR) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Proliferative Diabetic Retinopathy (NPDR). It presents in-depth analysis of Non-Proliferative Diabetic Retinopathy (NPDR) clinical trials ...

April 2019 57 pages

2019 Non-Rhabdomyosarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Non-Rhabdomyosarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Non-Rhabdomyosarcoma. It presents in-depth analysis of Non-Rhabdomyosarcoma clinical trials across markets and companies ...

April 2019 198 pages

2019 Nonseminomatous Testicular Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Nonseminomatous Testicular Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Nonseminomatous Testicular Cancer. It presents in-depth analysis of Nonseminomatous Testicular Cancer clinical trials ...

April 2019 44 pages

2019 Normal-Tension Glaucoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Normal-Tension Glaucoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Normal-Tension Glaucoma. It presents in-depth analysis of Normal-Tension Glaucoma clinical trials across markets and companies ...

April 2019 46 pages

2019 Obsessive Compulsive Disorder Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Obsessive Compulsive Disorder Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Obsessive Compulsive Disorder. It presents in-depth analysis of Obsessive Compulsive Disorder clinical trials ...

April 2019 122 pages

2019 Obstructive Sleep Apnea Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Obstructive Sleep Apnea Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Obstructive Sleep Apnea. It presents in-depth analysis of Obstructive Sleep Apnea clinical trials ...

April 2019 250 pages

2019 Occlusive Coronary Artery Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Occlusive Coronary Artery Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Occlusive Coronary Artery Disease. It presents in-depth analysis of Occlusive Coronary Artery Disease clinical trials ...

April 2019 46 pages

2019 Ocular Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Ocular Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Hypertension. It presents in-depth analysis of Ocular Hypertension clinical trials across markets and companies ...

April 2019 491 pages

2019 Ocular Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Ocular Melanoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Melanoma. It presents in-depth analysis of Ocular Melanoma clinical trials across markets and companies ...

April 2019 60 pages

2019 Ocular Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Ocular Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ocular Pain. It presents in-depth analysis of Ocular Pain clinical trials across markets and companies ...

April 2019 108 pages

2019 Olfactory Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Olfactory Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Olfactory Disorders. It presents in-depth analysis of Olfactory Disorders clinical trials across markets and companies ...

April 2019 43 pages

2019 Oligodendroglioma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Oligodendroglioma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oligodendroglioma. It presents in-depth analysis of Oligodendroglioma clinical trials across markets and companies ...

April 2019 264 pages

2019 Oligozoospermia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Oligozoospermia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oligozoospermia. It presents in-depth analysis of Oligozoospermia clinical trials across markets and companies ...

April 2019 49 pages

2019 Onchocerciasis (River Blindness) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Onchocerciasis (River Blindness) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onchocerciasis (River Blindness). It presents in-depth analysis of Onchocerciasis (River Blindness) clinical trials ...

April 2019 47 pages

2019 Onychomycosis (Tinea Unguium) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Onychomycosis (Tinea Unguium) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onychomycosis (Tinea Unguium). It presents in-depth analysis of Onychomycosis (Tinea Unguium) clinical trials ...

April 2019 94 pages

2019 Opioid Induced Bowel Dysfunction Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Opioid Induced Bowel Dysfunction Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Opioid Induced Bowel Dysfunction. It presents in-depth analysis of Opioid Induced Bowel Dysfunction clinical trials ...

April 2019 39 pages

2019 Opioid-Induced Constipation (OIC) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Opioid-Induced Constipation (OIC) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Opioid-Induced Constipation (OIC). It presents in-depth analysis of Opioid-Induced Constipation (OIC) clinical trials ...

April 2019 105 pages

2019 Opium Withdrawal Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Opium Withdrawal Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Opium Withdrawal Syndrome. It presents in-depth analysis of Opium Withdrawal Syndrome clinical trials ...

April 2019 70 pages

2019 Oppositional Defiant Disorder (ODD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... report- “2019 Oppositional Defiant Disorder (ODD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oppositional Defiant Disorder (ODD). It presents in-depth analysis of Oppositional Defiant Disorder (ODD) clinical trials ...

April 2019 40 pages

2019 Optic Neuritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Optic Neuritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Optic Neuritis. It presents in-depth analysis of Optic Neuritis clinical trials across markets and companies ...

April 2019 134 pages

2019 Optic Neuropathy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Optic Neuropathy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Optic Neuropathy. It presents in-depth analysis of Optic Neuropathy clinical trials across markets and companies ...

April 2019 181 pages

2019 Oral Leukoplakia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Oral Leukoplakia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oral Leukoplakia. It presents in-depth analysis of Oral Leukoplakia clinical trials across markets and companies ...

April 2019 40 pages

2019 Oral Mucositis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Oral Mucositis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oral Mucositis. It presents in-depth analysis of Oral Mucositis clinical trials across markets and companies ...

April 2019 192 pages

2019 Organophosphate and Carbamate Poisoning Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

... - “2019 Organophosphate and Carbamate Poisoning Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Organophosphate and Carbamate Poisoning. It presents in-depth analysis of Organophosphate and Carbamate Poisoning ...

April 2019 36 pages

2019 Oropharyngeal Candidiasis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Oropharyngeal Candidiasis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oropharyngeal Candidiasis. It presents in-depth analysis of Oropharyngeal Candidiasis clinical trials across markets and companies ...

April 2019 37 pages

2019 Orthostatic Hypotension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Orthostatic Hypotension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Orthostatic Hypotension. It presents in-depth analysis of Orthostatic Hypotension clinical trials across markets and companies ...

April 2019 75 pages

2019 Osteogenesis Imperfecta Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Osteogenesis Imperfecta Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Osteogenesis Imperfecta. It presents in-depth analysis of Osteogenesis Imperfecta clinical trials across markets and companies ...

April 2019 51 pages

2019 Osteomyelitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Osteomyelitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Osteomyelitis. It presents in-depth analysis of Osteomyelitis clinical trials across markets and companies ...

April 2019 66 pages

2019 Osteonecrosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Osteonecrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Osteonecrosis. It presents in-depth analysis of Osteonecrosis clinical trials across markets and companies ...

April 2019 66 pages

2019 Osteopenia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Osteopenia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Osteopenia. It presents in-depth analysis of Osteopenia clinical trials across markets and companies ...

April 2019 181 pages

2019 Osteosarcoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Osteosarcoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Osteosarcoma. It presents in-depth analysis of Osteosarcoma clinical trials across markets and companies ...

April 2019 238 pages

2019 Otitis Externa Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Otitis Externa Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Otitis Externa. It presents in-depth analysis of Otitis Externa clinical trials across markets and companies ...

April 2019 50 pages

2019 Otitis Media Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Otitis Media Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Otitis Media. It presents in-depth analysis of Otitis Media clinical trials across markets and companies ...

April 2019 300 pages

2019 Ovarian Hyperstimulation Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,799.00

The global clinical trial report- “2019 Ovarian Hyperstimulation Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ovarian Hyperstimulation Syndrome. It presents in-depth analysis of Ovarian Hyperstimulation Syndrome clinical trials ...

April 2019 84 pages

Filters

Search

Categories

1,428
60
12,968
1,223
4,429
2
1
12,593
2,818
15,138
67
8,921
1
1,229
586

Publishers

61,464

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
61,427

Price

Date

Pages

Offers